Researchers have identified thousands of chemical compounds that could be used to develop new malaria drugs, two studies published in the journal Nature on Wednesday show, the Wall Street Journal reports.
The Lancet released on Wednesday a special series on tuberculosis, which includes a series of papers and comments highlighting the need for new tools, the threat posed by drug-resistant strains, results of current control efforts and other issues about TB worldwide, Agence France-Presse reports.
“Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it â€“ by infusing the medicine into vaginal gels and contraceptive-style rings,” the Associated Press reports in a piece that examines researchers’ latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
BMJ News looks at how lack of access to drugs and resistance are undermining the fight against malaria.
This week’s issue of Science features news articles focusing on recent progress on malaria control in Africa and discussing future challenges, including drug resistance.
Also In Global Health News: Syphilis In China; HIV Vaccine Development; Tracking Malaria Outbreaks; Ecuador’s Maternity Law
Journal Perspective Piece DiscussesÂ Rising Number Of Syphilis Cases In China In 2008, almost 9,500 babies were born with syphilis in China, “a 12-fold increase over a five year period,”Â according to a New England Journal of Medicine perspective piece,Â theÂ “China Real Time Report” blog reports, addingÂ that the resurgence of the disease is…
IPS Reports On Stigma, Discrimination Among People Living With HIV/AIDSÂ In ChinaÂ In follow-up coverage of the news that China lifted a decades-old HIV/AIDSÂ travel ban, Inter Press Service reports that “erasing the stigma attached” to the virus is difficult in China.Â “‘What we are lacking now is in-depth HIV and AIDS…
The pharmaceutical company Pfizer said on Wednesday that it plans to increase the number of clinical trials it’s conducting in Singapore by 10 percent as part of an effort “to design drugs for diseases prevalent in the region,” Reuters reports.
Opinion Piece Outlines Challanges Facing Global Fund In an Economic Times opinion piece, Jeffrey Sachs of the Earth Institute at Columbia University outlines what he sees as “two huge challenges facing” the Global Fund to Fight AIDS, Tuberculosis and Malaria:Â “The first is lack of financing.Â … The second challenge is to…
Lancet Study Finds Level Of HIV Services For IDUs ‘Is Poor In Many Countries’ A Lancet studyÂ performed a systematic review ofÂ HIV prevention and treatment services targeting injecting drug users (IDUs) globallyÂ basedÂ on the availability of “core interventions for IDUs: needle and syringe programmes (NSPs), opioid substitution therapy (OST) and other drug…